SCOPUS 정보 검색 플랫폼

Oncology

Volumn 61, Issue SUPPL. 2, 2001, Pages 50-57

New combinations with Herceptin® in metastatic breast cancer

(2) Winer, Eric P a Burstein, Harold J a

a DANA FARBER CANCER INSTITUTE (United States)

Author keywords

Biological therapy; Combination therapy; HER2; Herceptin ; Metastatic breast cancer; Trastuzumab; Vinorelbine

Indexed keywords

ANASTROZOLE; ANTIINFECTIVE AGENT; CAPECITABINE; CARBOPLATIN; CISPLATIN; CYCLOPHOSPHAMIDE; DOCETAXEL; DOXORUBICIN; EPIDERMAL GROWTH FACTOR RECEPTOR; EPIRUBICIN; ETOPOSIDE; FLUOROURACIL; GEMCITABINE; HORMONE; LETROZOLE; METHOTREXATE; NAVELBINE; PACLITAXEL; RECEPTOR SUBTYPE; THIOTEPA; TRASTUZUMAB;

BREAST METASTASIS; CANCER COMBINATION CHEMOTHERAPY; CANCER HORMONE THERAPY; CANCER RESISTANCE; CARDIOTOXICITY; CLINICAL TRIAL; CONFERENCE PAPER; DISEASE COURSE; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERANCE; HUMAN; PRIORITY JOURNAL; TREATMENT OUTCOME;

ANTIBODIES, MONOCLONAL; ANTINEOPLASTIC AGENTS, HORMONAL; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BREAST NEOPLASMS; CLINICAL TRIALS, PHASE II; CLINICAL TRIALS, PHASE III; CYCLOPHOSPHAMIDE; DEOXYCYTIDINE; DOXORUBICIN; DRUG INTERACTIONS; DRUG SYNERGISM; EPIRUBICIN; FEMALE; FLUOROURACIL; HEART DISEASES; HEMATOLOGIC DISEASES; HUMANS; METHOTREXATE; NEOPLASM METASTASIS; NITRILES; ORGANOPLATINUM COMPOUNDS; PACLITAXEL; TAMOXIFEN; THIOTEPA; TREATMENT OUTCOME; TRIAZOLES; VINBLASTINE;

EID: 0034766737 PISSN: 00302414 EISSN: None Source Type: Journal
DOI: 10.1159/000055402 Document Type: Conference Paper

Times cited : (45)

References (40)

1
- 0000492316
- Health-related quality of life (HRQL) in women with HER2-overexpressing metastatic breast cancer (MBC) in a phase III study of Herceptin (R) plus chemotherapy versus chemotherapy alone
- (1999) Eur J Cancer , vol.35 , Issue.SUPPL. 4
- Baselga, J.¹ Kerrigan, M.² Burchmore, M.³ Ash, M.⁴

2
- 0032823487
- Phase II study of weekly intravenous trastuzumab (Herceptin) in patients with HER2/neu-overexpressing metastatic breast cancer
- (1999) Semin Oncol , vol.26 , Issue.SUPPL. 12 , pp. 78-83
- Baselga, J.¹ Tripathy, D.² Mendelsohn, J.³ Baughman, S.⁴ Benz, C.C.⁵ Dantis, L.⁶ Skarin, N.T.⁷ Seidman, A.D.⁸ Hudis, C.A.⁹ Moore, J.¹⁰ Rosen, P.P.¹¹ Twaddell, T.¹² Henderson, I.C.¹³ Norton, L.¹⁴

3
- 0029991439
- HER2 monoclonal antibody in patients with HER2/neu-overexpressing metastatic breast cancer
- (1996) J Clin Oncol , vol.14 , pp. 737-744
- Baselga, J.¹ Tripathy, D.² Mendelsohn, J.³ Baughman, S.⁴ Benz, C.C.⁵ Dantis, L.⁶ Sklarin, N.T.⁷ Seidman, A.D.⁸ Rosen, P.P.⁹ Twaddell, T.¹⁰ Henderson, I.C.¹¹ Norton, L.¹²

4
- 0001189715
- Safety profile of Herceptin (R) as a single agent and in combination with chemotherapy
- (1999) Eur J Cancer , vol.35 , Issue.SUPPL. 4
- Baselga, J.¹

5
- 0027074588
- Estrogen-dependent, tamoxifen-dependent tumorigenic growth of MCF-7 cells transfected with HER2/neu
- (1992) Breast Cancer Res Treat , vol.24 , pp. 85-95
- Benz, C.C.¹ Scott, G.K.² Sarup, J.C.³ Johnson, R.M.⁴ Tripathy, D.⁵ Coronado, E.⁶ Shepard, H.M.⁷ Osborne, C.K.⁸

6
- 0035873822
- Clinical activity of trastuzumab and vinorelbine in women with HER2-overexpressing metastatic breast cancer
- (2001) J Clin Oncol , vol.19 , pp. 2722-2730
- Burstein, H.J.¹ Kuter, I.² Campos, S.M.³ Gelman, R.S.⁴ Tribou, L.⁵ Parker, L.M.⁶ Manola, J.⁷ Younger, J.⁸ Matulonis, U.⁹ Bunnell, C.A.¹⁰ Partridge, A.H.¹¹ Richardson, P.G.¹² Clarke, K.¹³ Shulman, L.N.¹⁴ Winer, E.P.¹⁵

7
- 0026610881
- Humanization of an anti-p185HER2 antibody for human cancer therapy
- (1992) Proc Natl Acad Sci USA , vol.89 , pp. 4285-4289
- Carter, P.¹ Presta, L.² Gorman, C.M.³ Ridgway, J.B.⁴ Henner, D.⁵ Wong, W.L.⁶ Rowland, A.M.⁷ Kotts, C.⁸ Carver, M.E.⁹ Shepard, H.M.¹⁰

8
- 0032850677
- Multinational study of the efficacy and safety of humanized anti-HER2 monoclonal antibody in women who have HER2-overexpressing meta-static breast cancer that has progressed after chemotherapy for metastatic disease
- (1999) J Clin Oncol , vol.17 , pp. 2639-2648
- Cobleigh, M.A.¹ Vogel, C.L.² Tripathy, D.³ Robert, N.J.⁴ Scholl, S.⁵ Fehrenbacher, L.⁶ Wolter, J.M.⁷ Paton, V.⁸ Shak, S.⁹ Lieberman, G.¹⁰ Slamon, D.J.¹¹

9
- 0003236922
- A metanalysis of the interaction between Her2 and the response to endocrine therapy (ET) in metastatic breast cancer (MBC)
- (2000) Proc Am Soc Clin Oncol , vol.19
- De Laurentiis, M.¹ Arpino, G.² Massarelli, E.³ Carlomagno, C.⁴ Ciardiello, F.⁵ Tortora, G.⁶ Bianco, A.R.⁷ De Placido, S.⁸

10
- 0034754665
- Interaction between Herceptin® and taxanes
- (2001) Oncology , vol.61 , Issue.SUPPL. 2 , pp. 43-49
- Dïras, V.¹ Beuzeboc, P.² Laurence, V.³ Pierga, J.Y.⁴ Pouillart, P.⁵

11
- 0029015480
- Vinorelbine (Navelbine) in the treatment of breast cancer: The European experience
- (1995) Semin Oncol , vol.22 , Issue.2 SUPPL. 5 , pp. 22-28
- Fumoleau, P.¹ Delozier, T.² Extra, J.M.³ Canobbio, L.⁴ Delgado, F.M.⁵ Hurteloup, P.⁶

12
- 0027970234
- Vinorelbine is an active antiproliferative agent in pretreated advanced breast cancer patients: A phase II study
- (1994) J Clin Oncol , vol.12 , pp. 2094-2101
- Gasparini, G.¹ Caffo, O.² Barni, S.³ Frontini, L.⁴ Testolin, A.⁵ Guglielmi, R.B.⁶ Ambrosini, G.⁷

13
- 0034101194
- Palliative effect of chemotherapy: Objective tumor response is associated with symptom improvement in patients with metastatic breast cancer
- (2000) J Clin Oncol , vol.18 , pp. 2395-2405
- Geels, P.¹ Eisenhauer, E.² Bezjak, A.³ Zee, B.⁴ Day, A.⁵

14
- 0034074996
- Vinorelbine - A clinical review
- (2000) Br J Cancer , vol.82 , pp. 1907-1913
- Gregory, R.K.¹ Smith, I.E.²

15
- 0029092360
- Randomized comparison of vinorelbine and melphalan in anthracycline-refractory advanced breast cancer
- (1995) J Clin Oncol , vol.13 , pp. 2567-2574
- Jones, S.¹ Winer, E.² Vogel, C.³ Laufman, L.⁴ Hutchins, L.⁵ O'Rourke, M.⁶ Lembersky, B.⁷ Budman, D.⁸ Bigley, J.⁹ Hohneker, J.¹⁰

16
- 0000538295
- Therapeutic advantage of chemotherapy drugs in combination with Herceptin® against human breast cancer cells with HER2/neu overexpression
- abstract 467
- (1999) Breast Cancer Res Treat , vol.57 , pp. 114
- Konecny, G.¹ Pegram, M.D.² Beryt, M.³ Untch, M.⁴ Slamon, D.J.⁵

17
- 0033986779
- Anti-HER2 antibody enhances the growth inhibitory effect of anti-oestrogen on breast cancer cells expressing both oestrogen receptors and HER2
- (2000) Br J Cancer , vol.82 , pp. 46-51
- Kunisue, H.¹ Kurebayashi, J.² Otsuki, T.³ Tang, C.K.⁴ Kurosumi, M.⁵ Yamamoto, S.⁶ Tanaka, K.⁷ Doihara, H.⁸ Shimizu, N.⁹ Sonoo, H.¹⁰

18
- 0000747846
- A phase II trial of docetaxel and Herceptin in metastatic breast cancer patients overexpressing HER-2
- (2000) Proc Am Soc Clin Oncol , vol.19
- Kuzur, M.E.¹ Albain, K.S.² Huntington, M.O.³ Jones, S.F.⁴ Hainsworth, J.D.⁵ Greco, F.A.⁶ Erland, J.B.⁷ Vogel, C.L.⁸ Burris III, H.A.⁹

19
- 0000355801
- Phase II trial of weekly docetaxel (Taxotere) alone or in combination with trastuzumab (Herceptin) in patients with metastatic breast cancer
- (2000) Proc Am Soc Clin Oncol , vol.19
- Malik, U.¹ Sparano, J.A.² Manalo, J.³ Rajdev, L.⁴ Sarta, C.⁵ Hopkins, U.⁶ Fineberg, S.⁷

20
- 0000663660
- Weekly docetaxel (D) and rhumabher2 (H) combination therapy as first- or second-line treatment for metastatic breast cancer (MBC)
- (2000) Proc Am Soc Clin Oncol , vol.19
- Nicholson, B.P.¹ Thor, A.D.² Goldstein, L.J.³ Merkel, D.E.⁴ Gradishar, W.J.⁵ Sledge G.W., Jr.⁶

21
- 0003235310
- Health related quality of life (HRQL) of patients with first-line, single-agent, Trastuzumab (Herceptin) for metastatic HER-2 overexpressing breast cancer
- (2000) Proc Am Soc Clin Oncol , vol.19
- Osoba, D.¹ Burchmore, M.² Ash, M.³ Tripathy, D.⁴ Vogel, C.⁵

22
- 0032825105
- Health-related quality of life in women with metastatic breast cancer treated with trastuzumab (Herceptin)
- (1999) Semin Oncol , vol.26 , Issue.SUPPL. 12 , pp. 84-88
- Osoba, D.¹ Burchmore, M.²

23
- 0033118889
- Inhibitory effects of combinations of HER-2/neu antibody and chemotherapeutic agents used for treatment of human breast cancers
- (1999) Oncogene , vol.18 , pp. 2241-2251
- Pegram, M.¹ Hsu, S.² Lewis, G.³ Pietras, R.⁴ Beryt, M.⁵ Sliwkowski, M.⁶ Coombs, D.⁷ Baly, D.⁸ Kabbinavar, F.⁹ Slamon, D.¹⁰

24
- 0031903646
- HER2/neu monoclonal antibody plus cisplatin in patients with HER2/neu-overexpressing metastatic breast cancer refractory to chemotherapy treatment
- (1998) J Clin Oncol , vol.16 , pp. 2659-2671
- Pegram, M.D.¹ Lipton, A.² Hayes, D.F.³ Weber, B.L.⁴ Baselga, J.M.⁵ Tripathy, D.⁶ Baly, D.⁷ Baughman, S.A.⁸ Twaddell, T.⁹ Glaspy, J.A.¹⁰ Slamon, D.J.¹¹

25
- 0032825577
- Combination therapy with trastuzumab (Herceptin) and cisplatin for chemoresistant metastatic breast cancer: Evidence for receptor-enhanced chemosensitivity
- (1999) Semin Oncol , vol.26 , Issue.SUPPL. 12 , pp. 89-95
- Pegram, M.D.¹ Slamon, D.J.²

26
- 0028200221
- Antibody to HER-2/neu receptor blocks DNA repair after cisplatin in human breast and ovarian cancer cells
- (1994) Oncogene , vol.9 , pp. 1829-1838
- Pietras, R.J.¹ Fendly, B.M.² Chazin, V.R.³ Pegram, M.D.⁴ Howell, S.B.⁵ Slamon, D.J.⁶

27
- 0032578797
- Remission of human breast cancer xenografts on therapy with humanized monoclonal antibody to HER-2 receptor and DNA-reactive drugs
- (1998) Oncogene , vol.17 , pp. 2235-2249
- Pietras, R.J.¹ Pegram, M.D.² Finn, R.S.³ Maneval, D.A.⁴ Slamon, D.J.⁵

28
- 0025374582
- Hormonal modulation of HER2/neu protooncogene messenger ribonucleic acid and p185 protein expression in human breast cancer cell lines
- (1990) Cancer Res , vol.50 , pp. 3947-3951
- Read, L.D.¹ Keith, D.² Slamon, D.J.³ Katzenellenbogen, B.S.⁴

29
- 0028047628
- Vinorelbine as first-line chemotherapy for metastatic breast carcinoma
- (1994) J Clin Oncol , vol.12 , pp. 336-341
- Romero, A.¹ Rabinovich, M.G.² Vallejo, C.T.³ Perez, J.E.⁴ Rodriguez, R.⁵ Cuevas, M.A.⁶ Machiavelli, M.⁷ Lacava, J.A.⁸ Langhi, M.⁹ Romero Acuna, L.¹⁰

30
- 0035873815
- Weekly trastuzumab and paclitaxel therapy for metastatic breast cancer with analysis of efficacy by HER2 immunophenotype and gene amplification
- (2001) J Clin Oncol , vol.19 , pp. 2587-2595
- Seidman, A.D.¹ Fornier, M.N.² Esteva, F.J.³ Tan, L.⁴ Kaptain, S.⁵ Bach, A.⁶ Panageas, K.S.⁷ Arroyo, C.⁸ Valero, V.⁹ Currie, V.¹⁰ Gilewski, T.¹¹ Theodoulou, M.¹² Moynahan, M.E.¹³ Moasser, M.¹⁴ Sklarin, N.¹⁵ Dickler, M.¹⁶ D'Andrea, G.¹⁷ Cristofanilli, M.¹⁸ Rivera, E.¹⁹ Hortobagyi, G.N.²⁰ Norton, L.²¹ Hudis, C.A.²² more..

31
- 0029156749
- Quality of life in phase II trials: A study of methodology and predictive value in patients with advanced breast cancer treated with paclitaxel plus granulocyte colony stimulating factor
- (1995) J Natl Cancer Inst , vol.87 , pp. 1316-1322
- Seidman, A.D.¹ Portenoy, R.² Yao, T.J.³ Lepore, J.⁴ Mont, E.K.⁵ Kortmansky, J.⁶ Onetto, N.⁷ Ren, L.⁸ Grechko, J.⁹ Beltangady, M.¹⁰

32
- 0032844121
- Overview of the trastuzumab (Herceptin) anti-HER2 monoclonal antibody clinical program in HER2-overexpressing metastatic breast cancer
- (1999) Semin Oncol , vol.26 , Issue.SUPPL. 12 , pp. 71-77
- Shak, S.¹

33
- 37049183697
- Human breast cancer: Correlation of relapse and survival with amplification of the HER-2/neu oncogene
- (1987) Science , vol.235 , pp. 177-182
- Slamon, D.J.¹ Clark, G.M.² Wong, S.G.³ Levin, W.J.⁴ Ullrich, A.⁵ McGuire, W.L.⁶

34
- 0024337144
- Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer
- (1989) Science , vol.244 , pp. 707-712
- Slamon, D.J.¹ Godolphin, W.² Jones, L.A.³ Holt, J.A.⁴ Wong, S.G.⁵ Keith, D.E.⁶ Levin, W.J.⁷ Stuart, S.G.⁸ Udove, J.⁹ Ullrich, A.¹⁰

35
- 0035869407
- Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2
- (2001) N Engl J Med , vol.344 , pp. 783-792
- Slamon, D.J.¹ Leyland-Jones, B.² Shak, S.³ Fuchs, H.⁴ Paton, V.⁵ Bajamonde, A.⁶ Fleming, T.⁷ Eiermann, W.⁸ Wolter, J.⁹ Pegram, M.¹⁰ Baselga, J.¹¹ Norton, L.¹²

36
- 0028042373
- A phase II, multicentre, UK study of vinorelbine in advanced breast cancer
- (1994) Br J Cancer , vol.70 , pp. 990-993
- Twelves, C.J.¹ Dobbs, N.A.² Curnow, A.³ Coleman, R.E.⁴ Stewart, A.L.⁵ Tyrrell, C.J.⁶ Canney, P.⁷ Rubens, R.D.⁸

37
- 0001793693
- First-line, non-hormonal, treatment of woman with HER2 overexpressing metastatic breast cancer with Herceptin (trastuzumab, humanized anti-HER2 antibody)
- (2000) Proc Am Soc Clin Oncol , vol.19
- Vogel, C.¹ Cobleigh, M.² Tripathy, D.³ Harris, L.⁴ Fehrenbacher, L.⁵ Slamon, D.⁶ Ash, M.⁷ Novotny, W.⁸ Stewart, S.⁹ Shak, S.¹⁰

38
- 0032962603
- Vinorelbine as first-line chemotherapy for advanced breast cancer in women 60 years of age or older
- (1999) Ann Oncol , vol.10 , pp. 397-402
- Vogel, C.¹ O'Rourke, M.² Winer, E.³ Hochster, H.⁴ Chang, A.⁵ Adamkiewicz, B.⁶ White, R.⁷ McGuirt, C.⁸

39
- 0028848191
- Intravenous vinorelbine as first-line and second-line therapy in advanced breast cancer
- (1995) J Clin Oncol , vol.13 , pp. 2722-2730
- Weber, B.L.¹ Vogel, C.² Jones, S.³ Harvey, H.⁴ Hutchins, L.⁵ Bigley, J.⁶ Hohneker, J.⁷

40
- 0031015394
- Enhanced anti-proliferative activity of the combination of tamoxifen plus HER-2-neu antibody
- (1997) Breast Cancer Res Treat , vol.42 , pp. 1-5
- Witters, L.M.¹ Kumar, R.² Chincilli, V.M.³ Lipton, A.⁴

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.